Connsim Home Health Care is categorized under Home Health Care Services in Dallas, TX and active since 2000.
Connsim Home Health Care was established in 2000, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Simon Eyabi, Administrator at the company’s single location by writing to 5353 Maple Avenue, Dallas, Texas TX 75235 or by phoning (214) 920-2554. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Connsim Home Health Care |
| Contact Person: | Simon Eyabi, Administrator |
| Address: | 5353 Maple Avenue, Dallas, Texas 75235 |
| Phone Number: | (214) 920-2554 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6216100 |
| Share This Business: |
Connsim Home Health Care was started in 2000 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Simon Eyabi, Administrator for inquiries that concern Connsim Home Health Care by calling the company number (214) 920-2554, as your correspondence is most welcome. Additionally, the physical location of the single location of Connsim Home Health Care can be found at the coordinates 32.81835,-96.83296 as well as the street address 5353 Maple Avenue in Dallas, Texas 75235.
For its online presence, you may visit Connsim Home Health Care’s website at and engage with its social media outlets through on Twitter and on Facebook.